Thermo Fisher gets EU approval for $3.5B Phadia acquisition

08/29/2011 | MassDevice.com (Boston)

Thermo Fisher Scientific's purchase of Phadia, a maker of blood tests in Sweden, for $3.5 billion has received the green light from the European Commission. The transaction, which offers Thermo Fisher a broader footprint in specialty diagnostics, "would not raise competition concerns," the Commission said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Analyst
Delta Dental
Alpharetta, GA
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Chief Executive Officer
UCare Minnesota
Minneapolis, MN